The Trump administration's plan to cut federal research funding threatens 565 ongoing experiments involving cannabis, according to an MJBizDaily review and interviews with scientists and academics.
An accompanying freeze of new National Institutes of Health (NIH) grants is also stymieing future research at a key moment - and raising questions about the fate of marijuana rescheduling as well as suggesting profound consequences for the regulated MJ industry.
The NIH announced Feb. 7 that it would drastically reduce to no more than 15% the amount of "indirect costs" - money used to cover administrative and facility-related bills - financed by federal research grants.
Without fully funded indirect costs, "I literally cannot do my research," said Angela Bryan, a professor of psychology and neuroscience at the University of Colorado Boulder who's studied high-THC cannabis as well as the use of marijuana for pain, mood and sleep.
Universities immediately sued to block the NIH cuts, which are now on indefinite hiatus pending resolution of those legal challenges.
That forces researchers to continue to work despite the real possibility that a halt could happen at almost any time.
It also creates potential for yet another long-term headache for the $32 billion marijuana industry. Read story >
0 comentários:
Postar um comentário